Impact of weight loss on outcomes in patients with progressive fibrosing interstitial lung diseases (ILDs)

M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark), T. Maher (Los Angeles, CA, United States), Y. Inoue (Sakai City, Osaka, Japan), C. Miede (Sulzbach (Taunus), Germany), D. Lievens (Ingelheim am Rhein, Germany), B. Crestani (Paris, France)

Source: International Congress 2022 – Comorbidities and symptoms in interstitial lung diseases think out of the box

Session: Comorbidities and symptoms in interstitial lung diseases think out of the box
Session type: Thematic Poster
Number: 1153

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark), T. Maher (Los Angeles, CA, United States), Y. Inoue (Sakai City, Osaka, Japan), C. Miede (Sulzbach (Taunus), Germany), D. Lievens (Ingelheim am Rhein, Germany), B. Crestani (Paris, France). Impact of weight loss on outcomes in patients with progressive fibrosing interstitial lung diseases (ILDs). 1153

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.